Physician profile
Anas Alrefaee
NPI 1992238885
$17,576.24
in general payments reported to CMS, 2019-2025
18 companies · $9,478 in 2025
The $9,478 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $538 · 2022: $595 · 2023: $838 · 2024: $6,127 · 2025: $9,478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Food and Beverage: $5,873 · Education: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,319.20 |
| Food and Beverage | $5,873.02 |
| Education | $250.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,057.08 | 2023-2025 | Farapulse, Accolade Sr, Latitude Communicator Power Supply |
| Medtronic, INC. | $4,957.36 | 2024-2025 | Micra, Corevalve Evolut R, Cobalt Dr Mri Surescan |
| Biotronik INC. | $3,362.99 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $460.36 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $460.06 | 2021-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $401.40 | 2021-2024 | Lifevest |
| Pfizer INC. | $182.77 | 2022-2024 | |
| Edwards Lifesciences Corporation | $162.87 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Amgen INC. | $128.67 | 2021-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $114.84 | 2022-2024 | Camzyos, Eliquis |
| Chiesi USA, INC. | $86.89 | 2022 | |
| Abiomed | $53.44 | 2024 | Impella |
| Kiniksa Pharmaceuticals, LTD. | $49.32 | 2023 | Arcalyst |
| Lantheus Medical Imaging, INC. | $39.01 | 2021-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $16.94 | 2024 | Arcalyst |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $14.22 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.21 | 2022 | |
| Merck Sharp & Dohme LLC | $13.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anas Alrefaee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.